Healthcare Services

Computer-aided drug discovery market to reach $13.69B by 2030 at 12.5% CAGR

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Computer-Aided Drug Discovery Market Progress Between 2026 And 2030?

The computer-aided drug discovery market has experienced rapid growth in recent years. It is projected to expand from $7.56 billion in 2025 to $8.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. The market’s historical development can be attributed to factors such as the increasing complexity of drug development processes, rising R&D expenditure in pharmaceuticals, the expansion of computational biology capabilities, the growing availability of biological data, and the adoption of in silico modeling techniques.

The computer-aided drug discovery market size is projected for substantial expansion in the coming years. It is expected to reach $13.69 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is fueled by increasing investments in AI-enabled drug discovery, a rising demand for expedited drug development cycles, the expansion of personalized medicine research, a growing integration of machine learning in pharmacology, and the increasing use of cloud computing for large-scale simulations. Prominent trends throughout the forecast period include the increasing use of AI-driven virtual screening, a rising adoption of molecular docking simulations, the growing integration of genomic data in drug design, the expansion of cloud-based drug discovery platforms, and an enhanced focus on predictive modeling accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Key Drivers Are Affecting The Computer-Aided Drug Discovery Market Development?

The increasing occurrence of cancer is anticipated to propel the expansion of the computer-aided drug discovery market. Cancer is defined as a collection of diseases characterized by the unregulated proliferation and division of abnormal cells in the body. The growing incidence of cancer cases is attributed to multiple factors, including changes in lifestyle and urbanization, environmental pollution, consumption of tobacco and alcohol, and variations in healthcare access and awareness. Computer-aided drug discovery offers a means to develop drugs specifically aimed at cancer cells exhibiting particular genetic mutations, thereby opening avenues for more customized and effective cancer therapies. For example, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that around 165,000 new cancer cases were diagnosed in 2023. Projections further suggest that approximately 204,000 cases will be diagnosed annually by 2033, culminating in an estimated total of 1.9 million cancer cases between 2024 and 2033. Hence, the escalating prevalence of cancer cases is a significant driver for the computer-aided drug discovery market.

How Is Segmentation Applied In The Computer-Aided Drug Discovery Market Segment Analysis?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

What Trends Are Transforming The Computer-Aided Drug Discovery Market?

Major companies operating in the computer-aided drug discovery (CADD) market are developing advanced solutions, including artificial intelligence in drug discovery, to improve the accuracy, speed, and efficiency of identifying potential drug candidates, optimizing lead compounds, and facilitating the development of personalized medicine. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies, such as machine learning and deep learning, utilizing sophisticated algorithms to make the discovery and development of new drugs faster, more efficient, and more precise. As an example, in December 2023, Merck KGaA, a Germany-based science and technology company, introduced AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. Combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development by virtually screening compounds from over 60 billion chemical targets and recommending optimal synthesis routes. The platform has been trained on two decades of pharmaceutical R&D data to identify drug-like candidates with properties like non-toxicity and stability. By incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug manufacturing for efficiency and sustainability, aiming to reduce the cost and time associated with drug discovery.

Who Are The Companies Participating In The Computer-Aided Drug Discovery Market Environment?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Get The Full Computer-Aided Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Region Represents The Largest Share Of The Computer-Aided Drug Discovery Market?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Computer-Aided Drug Discovery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Informatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Computer Aided Oral And Maxillofacial Surgery Market Report 2026

https://www.thebusinessresearchcompany.com/report/computer-aided-oral-and-maxillofacial-surgery-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795